ES2721400T3 - Composición de Diclofenaco - Google Patents

Composición de Diclofenaco Download PDF

Info

Publication number
ES2721400T3
ES2721400T3 ES13830158T ES13830158T ES2721400T3 ES 2721400 T3 ES2721400 T3 ES 2721400T3 ES 13830158 T ES13830158 T ES 13830158T ES 13830158 T ES13830158 T ES 13830158T ES 2721400 T3 ES2721400 T3 ES 2721400T3
Authority
ES
Spain
Prior art keywords
composition
diclofenac
diclofenac composition
cps
mpa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13830158T
Other languages
English (en)
Other versions
ES2721400T8 (es
Inventor
Dinesh Shantilal Patel
Shachin Dinesh Patel
Shashikant Prabhudas Kurani
Madhavlal Govindlal Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Themis Medicare Ltd
Original Assignee
Themis Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54198802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2721400(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Themis Medicare Ltd filed Critical Themis Medicare Ltd
Application granted granted Critical
Publication of ES2721400T3 publication Critical patent/ES2721400T3/es
Publication of ES2721400T8 publication Critical patent/ES2721400T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición acuosa inyectable que comprende 25-200 mg/ml de Diclofenaco o sales del mismo, 5-50% (peso/v) de monoetil éter de dietilenglicol y agua como solvente principal en al menos 0.5 ml de solución, en donde dicha composición tiene una viscosidad entre aproximadamente 1 y aproximadamente 5 mPa s (cps) a 30 °C.
ES13830158T 2012-12-28 2013-12-27 Composición de Diclofenaco Active ES2721400T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3704MU2012 2012-12-28
PCT/IN2013/000805 WO2014102824A1 (en) 2012-12-28 2013-12-27 Diclofenac composition

Publications (2)

Publication Number Publication Date
ES2721400T3 true ES2721400T3 (es) 2019-07-31
ES2721400T8 ES2721400T8 (es) 2019-10-10

Family

ID=54198802

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13830158T Active ES2721400T3 (es) 2012-12-28 2013-12-27 Composición de Diclofenaco

Country Status (25)

Country Link
US (1) US20140187635A1 (es)
EP (1) EP2938325B8 (es)
JP (1) JP6117939B2 (es)
KR (1) KR101730284B1 (es)
CN (1) CN104968331A (es)
AP (1) AP2015008534A0 (es)
AU (1) AU2013368849B2 (es)
BR (1) BR112015015699B1 (es)
CL (1) CL2015001869A1 (es)
EA (1) EA035079B1 (es)
ES (1) ES2721400T3 (es)
HK (1) HK1211858A1 (es)
HU (1) HUE045030T2 (es)
IL (1) IL239395A0 (es)
MA (1) MA38292A1 (es)
MX (1) MX365375B (es)
MY (1) MY184886A (es)
PE (1) PE20151208A1 (es)
PH (1) PH12015501479B1 (es)
SG (1) SG11201504577UA (es)
SI (1) SI2938325T1 (es)
TR (1) TR201905806T4 (es)
UA (1) UA114123C2 (es)
WO (1) WO2014102824A1 (es)
ZA (1) ZA201504258B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
HUE066356T2 (hu) 2017-08-24 2024-07-28 Novo Nordisk As GLP-1 készítmények és alkalmazásaik
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
GR1009729B (el) * 2018-08-02 2020-05-15 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια Σταθερος ενεσιμος συνδυασμος
CN113038943B (zh) * 2018-11-16 2024-11-19 生化学工业株式会社 药物组合物
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
US12246024B2 (en) * 2019-12-13 2025-03-11 Free State Pharma Inc Compositions and methods for controlling cerumen production
PE20221575A1 (es) * 2020-02-18 2022-10-06 Novo Nordisk As Formulaciones farmaceuticas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
KR940701249A (ko) * 1991-07-04 1994-05-28 우에하라 아키라 진통제
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20050203000A1 (en) * 2003-03-26 2005-09-15 Sutter Diane E. Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
PT1574221E (pt) 2004-03-10 2007-07-09 Shimoda Biotech Pty Ltd Composições de diclofenac injectáveis estáveis
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
CN101123957B (zh) * 2005-02-01 2010-12-08 特罗伊卡药品有限公司 双氯芬酸及其药学上可接受盐的注射剂
BRPI0611170A2 (pt) * 2005-05-27 2010-08-17 Panacea Biotec Ltd composições injetáveis e processo para o preparo de tais composições
WO2010060798A1 (en) 2008-11-28 2010-06-03 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester

Also Published As

Publication number Publication date
HUE045030T2 (hu) 2019-12-30
EA035079B1 (ru) 2020-04-24
SG11201504577UA (en) 2015-07-30
BR112015015699B1 (pt) 2022-09-27
MA38292A1 (fr) 2017-06-30
EP2938325A1 (en) 2015-11-04
EA201591230A1 (ru) 2015-11-30
KR20150090250A (ko) 2015-08-05
MY184886A (en) 2021-04-29
PH12015501479B1 (en) 2019-11-15
MX2015008369A (es) 2016-03-01
EP2938325B1 (en) 2019-04-10
WO2014102824A1 (en) 2014-07-03
IL239395A0 (en) 2015-07-30
AU2013368849A1 (en) 2015-07-09
PE20151208A1 (es) 2015-08-23
UA114123C2 (xx) 2017-04-25
MX365375B (es) 2019-05-31
HK1211858A1 (en) 2016-06-03
SI2938325T1 (sl) 2019-06-28
EP2938325B8 (en) 2019-09-25
CN104968331A (zh) 2015-10-07
AP2015008534A0 (en) 2015-06-30
JP6117939B2 (ja) 2017-04-19
US20140187635A1 (en) 2014-07-03
JP2016508139A (ja) 2016-03-17
BR112015015699A2 (pt) 2017-07-11
WO2014102824A8 (en) 2014-10-02
PH12015501479A1 (en) 2015-09-21
ES2721400T8 (es) 2019-10-10
KR101730284B1 (ko) 2017-04-25
TR201905806T4 (tr) 2019-05-21
ZA201504258B (en) 2016-04-28
CL2015001869A1 (es) 2015-10-23
AU2013368849B2 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
UY35589A (es) Compuesto peptídico
PE20141906A1 (es) Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
UY36186A (es) Ácidos grasos novedosos y su uso en la conjugación con biomoléculas
CL2017000240A1 (es) Compuestos activos hacia bromodominios
MX2015002117A (es) Metodo y sistema para dispensar una composicion.
MX2018003776A (es) Composiciones para el cuidado bucal y metodos de uso.
MX2015011520A (es) Composiciones antimicrobianas.
CL2015003280A1 (es) Derivados de benzimidazol como inhibidores de bromodominio
CL2015002698A1 (es) Nuevos compuestos y composiciones para la inhibicion de fasn
GT201500312A (es) Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b
GT201200144A (es) Composición farmacéutica que comprende un agonista de glp-1, una insulina y metionina
MX2016007851A (es) Compuestos peptidomimeticos y conjugados anticuerpo-farmaco de estos.
ES2570958T3 (es) Composición para el tratamiento de la fístula
UY34992A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
MX367037B (es) Composiciones para el cuidado bucal y metodos de uso.
AR077629A1 (es) Mimetico de smac
CL2017001718A1 (es) Derivados de glucagón con estabilidad mejorada
UA114123C2 (xx) Водна композиція диклофенаку
MX2018007194A (es) Composiciones, sistemas de suministro y repuestos para emitir dos o mas composiciones.
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
MX2017003476A (es) Compuestos citotoxicos y anti-mitoticos, y metodos para usar los mismos.
UA115373C2 (uk) Стабільний рідкий склад amg 416 (велкалсетиду)
AR092468A1 (es) Concentrado liquido de transferencia de calor
AR094538A1 (es) Detergente